rroodd
IMO
Agree multiple drugs in pipeline is essential
Buying GDC0084 from Genentech and being responsible for all expenditure since 2016 was never going to work for a nano biotech
Current situation
Cantrixil requires a partner and GDC0084 requires up to $20m for phase 11b alone
After Anisina failed they were left with Cantrixil only and imo had no choice in buying a drug that is well beyond their capabilities financially
Look at the facts - The price at the reverse split was 40c and today years on the highest bid is 39c
DYOR
- Forums
- ASX - By Stock
- KZA
- KZA Media Thread
KZA Media Thread, page-123
-
-
- There are more pages in this discussion • 1,944 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online